Description Why 5-Amino-1MQ Is Redefining Lipid Metabolism Research Selective NNMT inhibitor -35% fat mass in 11 days without appetite reduction (preclinical model) Enzymatic Target NNMT Inhibitor Selective inhibition of nicotinamide N-methyltransferase (IC50 = 1.2 M)
No serious adverse events have been systematically documented in human use to date, though the absence of systematic reporting infrastructure in the research peptide space means that adverse events are almost certainly underreported
Circadian disruption is increasingly recognised as a key driver of: Accelerated aging Metabolic dysfunction Hormonal imbalance Cognitive decline Epitalon supports: Normalisation of sleepwake cycles Improved melatonin signalling Better alignment between central and peripheral clocks This explains why many individuals notice sleep improvement before other longevity effects
The absence of published human RCT data makes it a second-tier selection for skin despite its mechanistic interest
Known as the sleep hormone, melatonin is, more specifically, a neurochemical secreted by the pineal gland in the brain in response to the nighttime absence of light
[12] GHK-Cu peptide was observed to yield results within the study conditions at a low concentration